Tech Center 3700 • Art Units: 3792
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17642648 | Modulating Photosensitive Proteins with Mechanoluminescent Particles | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18295717 | NON-CONTACT MONITORING FOR NIGHT TREMORS OR OTHER MEDICAL CONDITIONS | Non-Final OA | Covidien LP |
| 18727252 | Computer Implemented Method for Classification of a Medical Relevance of a Deviation Between Cardiac Current Curves, Training Method and System | Non-Final OA | BIOTRONIK SE & Co. KG |
| 18374662 | METHODS AND SYSTEMS FOR DETECTING PACE PULSES | Final Rejection | Welch Allyn, Inc. |
| 18200269 | SYSTEMS AND METHODS FOR CONTROLLING AND OPTIMIZING CLOSED-LOOP NEUROMODULATION THERAPY | Non-Final OA | Medtronic, Inc. |
| 18137378 | SYSTEMS AND METHODS FOR TREATING METABOLIC SYNDROME WITH DORSAL ROOT GANGLION STIMULATION | Non-Final OA | Medtronic, Inc. |
| 18331144 | Machine Learning (ML)-based Disease-Detection System Using Detection Animals | Final Rejection | Spotitearly Ltd. |
| 18726966 | AUTOMATED EXTERNAL DEFIBRILLATOR | Non-Final OA | NIHON KOHDEN CORPORATION |
| 18594623 | CONTINUOUS UNIPOLAR IMPEDANCE MONITORING TO DIAGNOSE LEFT BUNDLE BRANCH AREA PACING LEAD STABILITY | Non-Final OA | Cardiac Pacemakers, Inc. |
| 18632533 | PUMP-OUTLET TUBE | Non-Final OA | MAGENTA MEDICAL LTD |
| 18165645 | APPARATUS AND A METHOD FOR ADAPTIVE LIGHT FRACTIONATION IN PHOTOTHERAPY | Final Rejection | Modulight Corporation |
| 18274921 | MULTI-SENSOR WEARABLE PATCH | Non-Final OA | Biotricity Inc. |
| 18446614 | HEALTH DIAGNOSTIC SYSTEM AND A METHOD FOR ANALYZING THE HEALTH OF AN ANIMAL | Final Rejection | Laboratory of Data Discovery for Health Limited |
| 18332363 | MANUAL DRIVE FUNCTION FOR SURGICAL TOOLS | Final Rejection | Cilag GbmH International |
| 17917710 | LED ILLUMINATOR AND COMPLEXION RECOVERY METHOD USING SAME | Non-Final OA | KOREATECH CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy